advertisement

Topcon

Zhang Z 23

Showing records 1 to 23 | Display all abstracts from Zhang Z

106793 Relationship between plasma amino acid and carnitine levels and primary angle-closure glaucoma based on mass spectrometry metabolomics
Zhang Z
Experimental Eye Research 2023; 227: 109366
105912 Aqueous Humor Growth Factor Levels and Trabeculectomy Outcomes in Primary Open-Angle Glaucoma Patients: A 2-Year Prospective Study
Qian T
Translational vision science & technology 2022; 11: 2
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhao Y
Drug Delivery 2022; 29: 613-623
106580 RSAP-Net: joint optic disc and cup segmentation with a residual spatial attention path module and MSRCR-PT pre-processing algorithm
Jiang Y
BMC bioinformatics 2022; 23: 523
105912 Aqueous Humor Growth Factor Levels and Trabeculectomy Outcomes in Primary Open-Angle Glaucoma Patients: A 2-Year Prospective Study
Fu M
Translational vision science & technology 2022; 11: 2
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Huang C
Drug Delivery 2022; 29: 613-623
106793 Relationship between plasma amino acid and carnitine levels and primary angle-closure glaucoma based on mass spectrometry metabolomics
Li L
Experimental Eye Research 2023; 227: 109366
106580 RSAP-Net: joint optic disc and cup segmentation with a residual spatial attention path module and MSRCR-PT pre-processing algorithm
Ma Z
BMC bioinformatics 2022; 23: 523
106793 Relationship between plasma amino acid and carnitine levels and primary angle-closure glaucoma based on mass spectrometry metabolomics
Zhang C
Experimental Eye Research 2023; 227: 109366
106580 RSAP-Net: joint optic disc and cup segmentation with a residual spatial attention path module and MSRCR-PT pre-processing algorithm
Wu C
BMC bioinformatics 2022; 23: 523
105912 Aqueous Humor Growth Factor Levels and Trabeculectomy Outcomes in Primary Open-Angle Glaucoma Patients: A 2-Year Prospective Study
Ye L
Translational vision science & technology 2022; 11: 2
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhang Z
Drug Delivery 2022; 29: 613-623
106580 RSAP-Net: joint optic disc and cup segmentation with a residual spatial attention path module and MSRCR-PT pre-processing algorithm
Zhang Z
BMC bioinformatics 2022; 23: 523
105912 Aqueous Humor Growth Factor Levels and Trabeculectomy Outcomes in Primary Open-Angle Glaucoma Patients: A 2-Year Prospective Study
Du J
Translational vision science & technology 2022; 11: 2
106793 Relationship between plasma amino acid and carnitine levels and primary angle-closure glaucoma based on mass spectrometry metabolomics
Zhang P
Experimental Eye Research 2023; 227: 109366
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Hong J; Xu J
Drug Delivery 2022; 29: 613-623
106580 RSAP-Net: joint optic disc and cup segmentation with a residual spatial attention path module and MSRCR-PT pre-processing algorithm
Yan W
BMC bioinformatics 2022; 23: 523
106793 Relationship between plasma amino acid and carnitine levels and primary angle-closure glaucoma based on mass spectrometry metabolomics
Fang Z
Experimental Eye Research 2023; 227: 109366
105912 Aqueous Humor Growth Factor Levels and Trabeculectomy Outcomes in Primary Open-Angle Glaucoma Patients: A 2-Year Prospective Study
Xu X; Zhang Z
Translational vision science & technology 2022; 11: 2
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Sun X
Drug Delivery 2022; 29: 613-623
106793 Relationship between plasma amino acid and carnitine levels and primary angle-closure glaucoma based on mass spectrometry metabolomics
Li J
Experimental Eye Research 2023; 227: 109366
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Sun J
Drug Delivery 2022; 29: 613-623
106793 Relationship between plasma amino acid and carnitine levels and primary angle-closure glaucoma based on mass spectrometry metabolomics
Wang S
Experimental Eye Research 2023; 227: 109366

Issue 23-3

Change Issue


advertisement

Oculus